| Literature DB >> 33731770 |
Emmanuel Minet1, Linsey E Haswell1, Sarah Corke1, Anisha Banerjee1, Andrew Baxter1, Ivan Verrastro1, Francisco De Abreu E Lima1, Tomasz Jaunky1, Simone Santopietro1, Damien Breheny1, Marianna D Gaça2.
Abstract
Mucus hypersecretion contributes to lung function impairment observed in COPD (chronic obstructive pulmonary disease), a tobacco smoking-related disease. A detailed mucus hypersecretion adverse outcome pathway (AOP) has been constructed from literature reviews, experimental and clinical data, mapping key events (KEs) across biological organisational hierarchy leading to an adverse outcome. AOPs can guide the development of biomarkers that are potentially predictive of diseases and support the assessment frameworks of nicotine products including electronic cigarettes. Here, we describe a method employing manual literature curation supported by a focused automated text mining approach to identify genes involved in 5 KEs contributing to decreased lung function observed in tobacco-related COPD. KE genesets were subsequently confirmed by unsupervised clustering against 3 different transcriptomic datasets including (1) in vitro acute cigarette smoke and e-cigarette aerosol exposure, (2) in vitro repeated incubation with IL-13, and (3) lung biopsies from COPD and healthy patients. The 5 KE genesets were demonstrated to be predictive of cigarette smoke exposure and mucus hypersecretion in vitro, and less conclusively predict the COPD status of lung biopsies. In conclusion, using a focused automated text mining and curation approach with experimental and clinical data supports the development of risk assessment strategies utilising AOPs.Entities:
Year: 2021 PMID: 33731770 PMCID: PMC7969622 DOI: 10.1038/s41598-021-85345-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379